Concepedia
2
Publications
75
Citations
H-Index
2014
Active since
Affiliations
Janssen (Belgium)(Current)
Janssen (United States)
Jim Proctor is an author at Janssen (Belgium) specializing in cancer research, medicine, and pathology.
Top concepts
MedicinePathologyPharmacologyCancer ResearchToxicologyGlycobiologyTumor Biology
Publications per year
2014–2014
Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin
Sandra De Jonghe, Jim Proctor, Petra Vinken et al. · Chemico-Biological Interactions · 2014 · 54 citations
Chemoprevention Strategy, Sglt2 Inhibitor Canagliflozin, Oncogenic Agent +6
Carbohydrate malabsorption mechanism for tumor formation in rats treated with the SGLT2 inhibitor canagliflozin
Rao N. V. S. Mamidi, Jim Proctor, Sandra De Jonghe et al. · Chemico-Biological Interactions · 2014 · 21 citations
Chemoprevention Strategy, Sglt2 Inhibitor Canagliflozin, Medicine +8
Rows per page
1–2 of 2